+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5914577
Description Jump to:

Vaccine Adjuvants Market Growth & Trends

The global vaccine adjuvants market is expected to reach USD 4.86 billion by 2030. The market is anticipated to grow at a CAGR of 4.32% from 2025 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Vaccine Adjuvants Market Report Highlights

  • The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2024
  • The infectious diseases segment accounted for the largest revenue share of 68.0% in 2024. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
  • The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2024
  • North America dominated the market and accounted for the largest revenue share of 39.4% in 2024. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. Administration type
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. Administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Vaccine Adjuvants Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis
4.1. Vaccine Adjuvants Market: Key Takeaways
4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
4.3. Pathogen
4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Adjuvant emulsion
4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Particulate
4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Combination
4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis
5.1. Vaccine Adjuvants Market: Key Takeaways
5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
5.3. Infectious diseases
5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cancer
5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis
6.1. Vaccine Adjuvants Market: Key Takeaways
6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intradermal
6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Intranasal
6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Intramuscular
6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Vaccine Adjuvants Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.4. Mexico
7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Argentina
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. GSK
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Novartis/CSL
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Agenus
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Adjuvance
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Novavax
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SPI Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Invivogen
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Avanti Polar Lipids
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Brentagg
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 12 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 15 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 16 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 17 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 18 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 19 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 20 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 21 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 22 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 23 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 24 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 25 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 26 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 27 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 28 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 29 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 30 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 31 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 32 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 33 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 34 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 35 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 37 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 38 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 40 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 41 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 42 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 44 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 45 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 47 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 48 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 49 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 50 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 51 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 52 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 53 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 54 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 55 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
Table 56 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 57 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 58 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 59 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 60 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 62 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 63 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 64 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 65 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 66 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 68 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 69 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 70 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Vaccine adjuvants: Market outlook
Fig. 8 Vaccine adjuvants: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Vaccine adjuvants market driver impact
Fig. 14 Vaccine adjuvants market restraint impact
Fig. 15 Vaccine adjuvants market strategic initiatives analysis
Fig. 16 Vaccine adjuvants market: Type movement analysis
Fig. 17 Vaccine adjuvants market: Type outlook and key takeaways
Fig. 18 Pathogen market estimates and forecasts, 2018 - 2030
Fig. 19 Adjuvant emulsion market estimates and forecasts, 2018 - 2030
Fig. 20 Particulate market estimates and forecasts, 2018 - 2030
Fig. 21 Combination market estimates and forecasts, 2018 - 2030
Fig. 22 Others market estimates and forecasts, 2018 - 2030
Fig. 23 Vaccine adjuvants market: Application movement analysis
Fig. 24 Vaccine adjuvants market: Application outlook and key takeaways
Fig. 25 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 26 Cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Others market estimates and forecasts, 2018 - 2030
Fig. 28 Vaccine adjuvants market: Administration movement analysis
Fig. 29 Vaccine adjuvants market: Administration outlook and key takeaways
Fig. 30 Oral market estimates and forecasts, 2018 - 2030
Fig. 31 Intradermal market estimates and forecasts, 2018 - 2030
Fig. 32 Intranasal market estimates and forecasts, 2018 - 2030
Fig. 33 Intramuscular market estimates and forecasts, 2018 - 203
Fig. 34 Others market estimates and forecasts, 2018 - 2030
Fig. 35 Global vaccine adjuvants market: Regional movement analysis
Fig. 36 Global vaccine adjuvants market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018 - 2030
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
Fig. 39 Canada market estimates and forecasts, 2018 - 2030
Fig. 40 Mexico market estimates and forecasts, 2018 - 2030
Fig. 41 Europe. market estimates and forecasts, 2018 - 2030
Fig. 42 UK market estimates and forecasts, 2018 - 2030
Fig. 43 Germany market estimates and forecasts, 2018 - 2030
Fig. 44 France market estimates and forecasts, 2018 - 2030
Fig. 45 Italy market estimates and forecasts, 2018 - 2030
Fig. 46 Spain market estimates and forecasts, 2018 - 2030
Fig. 47 Denmark market estimates and forecasts, 2018 - 2030
Fig. 48 Sweden market estimates and forecasts, 2018 - 2030
Fig. 49 Norway market estimates and forecasts, 2018 - 2030
Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 51 Japan market estimates and forecasts, 2018 - 2030
Fig. 52 China market estimates and forecasts, 2018 - 2030
Fig. 53 India market estimates and forecasts, 2018 - 2030
Fig. 54 Australia market estimates and forecasts, 2018 - 2030
Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 63 UAE market estimates and forecasts, 2018 - 2030
Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • GlaxoSmithKline plc.
  • Novavax, Inc.
  • Adjuvance Technologies, Inc.
  • SPI Pharma
  • Agenus, Inc.
  • CSL Limited
  • InvivoGen
  • Brenntag Biosector

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.81 billion
Forecasted Market Value ( USD ) by 2030 $ 4.86 billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Vaccine Adjuvants Market by Product, Route of Administration, Disease, Application - Global Forecast 2025-2030 - Product Image

Vaccine Adjuvants Market by Product, Route of Administration, Disease, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Vaccine Adjuvants - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vaccine Adjuvants - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032 - Product Image

Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029 - Product Image

Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029

  • Report
  • 389 Pages
  • Global
From
Vaccine Adjuvants Global Market Report 2024 - Product Image

Vaccine Adjuvants Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.